Tonghua Dongbao Pharmaceutical Co., Ltd.SSE: 600867

Announcement on Obtaining Overseas Drug Registration Certificate for Insulin Aspart Injection

· Issued by Tonghua Dongbao Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 2 pages · Chinese

Summary by 6ix AI

Tonghua Dongbao Pharmaceutical Co., Ltd. has announced that it has received an overseas drug registration certificate for Insulin Aspart Injection from the Ministry of Public Health and Social Welfare of the Dominican Republic.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Announcement on Obtaining Overseas Drug Registration Certificate for Insulin Aspart Injection

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Tonghua Dongbao Pharmaceutical Co., Ltd. on 6ix

Earlier from Tonghua Dongbao Pharmaceutical

Later from Tonghua Dongbao Pharmaceutical

All Tonghua Dongbao Pharmaceutical news releases